Publications by authors named "Ralf Eschbach"

Claim this Profile
V
Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patients.
Freba Grawe, Ricarda Ebner, Thomas Geyer, Leonie Beyer, Michael Winkelmann, Ralf Eschbach

Eur Radiol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs.
Freba Grawe, Natalie Rosenberger, Maria Ingenerf, Leonie Beyer, Ralf Eschbach

Cancer Imaging· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [F]SiTATE.
Ralf S Eschbach, Markus Hofmann, Lukas Späth, Gabriel T Sheikh, Astrid Delker

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma.
Philipp M Kazmierczak, Neal C Burton, Georg Keinrath, Heidrun Hirner-Eppeneder, Moritz J Schneider, Ralf S Eschbach

PLoS One· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT.
Wolfgang G Kunz, Ralf S Eschbach, Robert Stahl, Philipp M Kazmierczak, Peter Bartenstein

Cancer Imaging· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanoma.
Ralf S Eschbach, Philipp M Kazmierczak, Maurice M Heimer, Andrei Todica, Heidrun Hirner-Eppeneder

Cancer Imaging· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation.
Ralf Stefan Eschbach, Dirk-Andre Clevert, Heidrun Hirner-Eppeneder, Michael Ingrisch, Matthias Moser

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer.
Philipp M Kazmierczak, Andrei Todica, Franz-Josef Gildehaus, Heidrun Hirner-Eppeneder, Matthias Brendel, Ralf S Eschbach

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
αvß3-Integrin-Targeted Magnetic Resonance Imaging for the Assessment of Early Antiangiogenic Therapy Effects in Orthotopic Breast Cancer Xenografts.
Philipp Maximilian Kazmierczak, Moritz Schneider, Thomas Habereder, Heidrun Hirner-Eppeneder, Ralf S Eschbach

Invest Radiol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring Cell Death in Regorafenib-Treated Experimental Colon Carcinomas Using Annexin-Based Optical Fluorescence Imaging Validated by Perfusion MRI.
Philipp M Kazmierczak, Egon Burian, Ralf Eschbach, Heidrun Hirner-Eppeneder, Matthias Moser

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation.
Ralf S Eschbach, Wolfgang P Fendler, Philipp M Kazmierczak, Marcus Hacker, Axel Rominger

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DCE-MRI biomarkers for monitoring an anti-angiogenic triple combination therapy in experimental hypopharynx carcinoma xenografts with immunohistochemical validation.
Alexander Sterzik, Philipp M Paprottka, Pamela Zengel, Heidrun Hirner, Svenja Roßpunt, Ralf Eschbach

Acta Radiol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib effects on human colon carcinoma xenografts monitored by dynamic contrast-enhanced computed tomography with immunohistochemical validation.
Clemens C Cyran, Philipp M Kazmierczak, Heidrun Hirner, Matthias Moser, Michael Ingrisch, Ralf Eschbach

PLoS One· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.
Clemens C Cyran, Jobst C von Einem, Philipp M Paprottka, Bettina Schwarz, Michael Ingrisch, Ralf Eschbach

Invest Radiol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis